谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

813MO Phase I Trial of a Personalized Multi-Peptide Vaccine Combined with the TLR1/2 Ligand XS15 under Bruton-Tyrosine-Kinase Inhibitor (btki) Treatment in Chronic Lymphocytic Leukemia (CLL) Patients

C. Hackenbruch,J.S. Heitmann, S. Jung,Y. Maringer,M. Wacker,A. Nelde,M. Marconato, L. Zieschang, C. Kammer, M.T. Özbek, M. Richter,M. Denk,H.R. Salih,J.S. Walz

Annals of Oncology（2024）

引用 0|浏览3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要